Jubi de Haan

Jubi de Haan is a Researcher at Erasmus MC in the Department of Intensive Care in Rotterdam, Netherlands. With a significant research output focused on liver-related critical care, Dr. de Haan's work bridges intensive care medicine and hepatology, particularly examining outcomes for patients with acute-on-chronic liver failure (ACLF) and those requiring liver transplantation.

Dr. de Haan's primary research interests include:

• Acute on Chronic Liver Failure (100% research focus)
• Liver Transplantation (69% research focus)
• Intensive Care Unit Management for Liver Disease (41% research focus)
• Machine Perfusion Technology (33% research focus)
• Liver Function Assessment (33% research focus)
• Cytochrome P450 1A2 Metabolism (33% research focus)

Recent research by Dr. de Haan has focused on transplant-free survival following ICU admission for ACLF, inequities in liver transplantation access across Europe, and innovative techniques for assessing donor liver function during machine perfusion. The work demonstrates a strong emphasis on improving outcomes for critically ill patients with liver disease through both clinical research and technological innovation, with several publications appearing in high-impact journals including Journal of Hepatology and Liver Transplantation.

Dr. de Haan's publications have received significant attention in the medical community, with multiple papers referenced in clinical guideline sources. The 2021 paper on liver transplantation for ACLF patients has garnered over 147 citations and 345 downloads, indicating substantial impact in the field.